五洲医疗
(301234)
| 流通市值：4.42亿 | | | 总市值：16.32亿 |
| 流通股本：1842.80万 | | | 总股本：6800.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 90,040,221.08 | 533,679,925.02 | 414,652,854.08 | 276,629,497.77 |
| 营业收入 | 90,040,221.08 | 533,679,925.02 | 414,652,854.08 | 276,629,497.77 |
| 二、营业总成本 | 80,849,921.31 | 463,331,172.92 | 349,609,980 | 232,979,972.2 |
| 营业成本 | 75,271,891.42 | 419,950,006.1 | 325,147,270.24 | 217,800,723.95 |
| 税金及附加 | 893,867.26 | 2,669,847.09 | 1,863,352.04 | 1,215,354.8 |
| 销售费用 | 2,229,279.53 | 15,305,821.92 | 9,348,026.97 | 6,265,411.4 |
| 管理费用 | 3,266,177.73 | 19,946,827.57 | 12,481,126.79 | 8,188,043.25 |
| 研发费用 | 2,083,857.9 | 13,478,535.3 | 8,191,394.18 | 5,221,805.09 |
| 财务费用 | -2,895,152.53 | -8,019,865.06 | -7,421,190.22 | -5,711,366.29 |
| 其中:利息费用 | 1,391.24 | 12,244.19 | 8,555.13 | 5,433.42 |
| 其中:利息收入 | 1,711,770.77 | 5,097,268.36 | 3,458,136.63 | -1,920,697.63 |
| 加:公允价值变动收益 | -226,403.49 | -1,340,350.16 | -1,967,410.74 | -1,548,842.36 |
| 加:投资收益 | 311,723.18 | 3,624,942.91 | 3,492,204.42 | 2,712,471.96 |
| 资产处置收益 | 0 | - | 0 | - |
| 资产减值损失(新) | -1,153,004.67 | -2,731,496.49 | -2,065,106.27 | -786,291.66 |
| 信用减值损失(新) | 1,543,400.01 | -3,888,362.39 | -1,461,046.06 | -2,011,080.55 |
| 其他收益 | 2,291,047.37 | 2,461,791.25 | 1,830,833.36 | 1,323,417.97 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 11,957,062.17 | 68,475,277.22 | 64,872,348.79 | 43,339,200.93 |
| 加:营业外收入 | 50 | 3,413,366.08 | 12,906.23 | 1,715.12 |
| 减:营业外支出 | 12,274 | 950,370.57 | 786,132.62 | 459,264.28 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 11,944,838.17 | 70,938,272.73 | 64,099,122.4 | 42,881,651.77 |
| 减:所得税费用 | 2,060,162.57 | 10,673,217.29 | 10,053,078.88 | 6,684,078.59 |
| 六、净利润 | 9,884,675.6 | 60,265,055.44 | 54,046,043.52 | 36,197,573.18 |
| 持续经营净利润 | 9,884,675.6 | 60,265,055.44 | 54,046,043.52 | 36,197,573.18 |
| 归属于母公司股东的净利润 | 9,884,675.6 | 60,265,055.44 | 54,046,043.52 | 36,197,573.18 |
| (一)基本每股收益 | 0.15 | 0.89 | 0.79 | 0.53 |
| (二)稀释每股收益 | 0.15 | 0.89 | 0.79 | 0.53 |
| 九、综合收益总额 | 9,884,675.6 | 60,265,055.44 | 54,046,043.52 | 36,197,573.18 |
| 归属于母公司股东的综合收益总额 | 9,884,675.6 | 60,265,055.44 | 54,046,043.52 | 36,197,573.18 |
| 公告日期 | 2024-04-16 | 2024-04-16 | 2023-10-24 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |